NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Travere Therapeutics, Inc. (“Travere” or the “Company”) (NASDAQ: TVTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

ANET's networking investment thesis remains robust, as observed in the growing contract wins across the federal/ enterprise sector and the higher multi-year backlogs. The same has been observed in the management's promising FQ2'25 guidance and the richer cash flow story, underscoring their ability to monetize the ongoing AI/ data center boom. Combined with the richer balance sheet and the cancellation of its elevated SBC expenses, we believe that ANET remains well-positioned to outperform ahead.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ADTRAN Holdings, Inc. (“ADTRAN” or the “Company”) (NASDAQ: ADTN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

WASHINGTON , June 2, 2025 /PRNewswire/ -- Cogent Communications Holdings, Inc. (NASDAQ: CCOI) (the "Company" or "Cogent") today announced that two of its wholly owned subsidiaries, Cogent Communications Group, LLC (f/k/a Cogent Communications Group, Inc.) ("Cogent Group") and Cogent Finance, Inc. (the "Co-Issuer" and, together with Cogent Group, the "Issuers"), intend to commence an offering of $600.0 million aggregate principal amount of senior secured notes due 2032 (the "Notes") to be offered and sold only to persons reasonably believed to be "qualified institutional buyers" in an unregistered offering pursuant to Rule 144A under the U.S. Securities Act of 1933, as …

CI gains 14.7% YTD as Evernorth and Cigna Healthcare drive growth, but rising expenses and debt pose challenges.

PCTY's strong Q3, expanding AI-powered tools and a steady client base present a compelling entry point in the stock for investors.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zenas To Contact Him Directly To Discuss Their Options

Moderna's new COVID vaccine approval targets a broader high-risk population, but the market remains skeptical due to limited revenue prospects and ongoing losses. Management is pivoting to cost-cutting, pipeline focus, and realistic revenue guidance after overreaching post-pandemic and burning through cash on speculative projects. Despite leadership changes at HHS and FDA and loss of government funding, Moderna could outperform 2025 guidance if vaccination rates and combo shots gain traction.

TSMC has evolved into the keystone of the global order, in an era where power is defined by semiconductors. As the West retools for autonomy, TSMC becomes the thread stitching peace, tech, and deterrence into one fabric. China may contest borders, but it can't destroy global interdependence; TSMC's dispersion strategy binds allies faster than adversaries can decouple from world order dynamics.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Photronics, Inc. (“Photronics” or the “Company”) (NASDAQ: PLAB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Apple Inc. (“Apple” or the “Company”) (NASDAQ: AAPL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The Investment Committee give you their top stocks to watch for the second half.

Walt Disney is laying off several hundred employees globally in teams including marketing for film and television, publicity, and casting and development, a source familiar with the matter said on Monday.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Hallador Energy Company (“Hallador” or the “Company”) (NASDAQ: HNRG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

PEP's international momentum, led by strong beverage sales, localization and supply chain investments, fuels optimism despite U.S. softness and FX headwinds.

INOD and SOUN are riding the AI wave with surging sales, but their risk-reward profiles tell two very different stories.

Carvana (CVNA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.